Ottawa, April 28, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Ontario budget released by Finance Minister Peter Bethlenfalvy today. […]
Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Federal Government’s recent announcement on the […]
IMC is pleased with the ongoing commitments to increased access to innovative medicines and treatments […]
Ottawa, March 31, 2022 – Innovative Medicines Canada (IMC) is disappointed by the latest Patented Medicine Prices Review Board (PMPRB) Annual Report, which continues to disseminate inaccurate representation of data […]
IMC welcomes the federal government’s renewed commitment to enhancing access […]